Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Alpha Cognition Inc. (ACOG : NSDQ)

• Company Description    Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia. Number of Employees: 71

• Price / Volume Information    Yesterday's Closing Price: $5.85 Daily Weekly Monthly 20 Day Moving Average: 36,242 shares Shares Outstanding: 21.77 (millions) Market Capitalization: $127.38 (millions) Beta: 2.38 52 Week High: $11.54 52 Week Low: $4.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -14.60% -18.77% 12 Week -2.50% -9.87% Year To Date -10.00% -17.68%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1452 Hughes Rd. Ste. 200 - Grapevine,TX 76051 CAN ph: 858-344-4375 fax: - ir@alphacognition.com http://www.alphacognition.com

• General Corporate Information    Officers Michael McFadden - Chief Executive Officer and Director Henry Du - Vice President of Finance and Accounting and inter Len Mertz - Director Kenneth Cawkell - Director Robert Wills - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 02074J501 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 21.77 Most Recent Split Date: 11.00 (0.04:1) Beta: 2.38 Market Capitalization: $127.38 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.40 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.34 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.22 Price/Cash Flow: - Price / Sales: 11.77 EPS Growth vs. Year Ago Period: -85.00% vs. Previous Quarter: -23.33% Sales Growth vs. Year Ago Period: 20.66% vs. Previous Quarter: 26.53% ROE 03/31/26 - -58.35 12/31/25 - -55.71 09/30/25 - -64.13 ROA 03/31/26 - -45.99 12/31/25 - -43.78 09/30/25 - -50.12 Current Ratio 03/31/26 - 12.64 12/31/25 - 8.65 09/30/25 - 6.69 Quick Ratio 03/31/26 - 11.52 12/31/25 - 8.09 09/30/25 - 6.03 Operating Margin 03/31/26 - -276.49 12/31/25 - -249.35 09/30/25 - - Net Margin 03/31/26 - -232.23 12/31/25 - -202.23 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - -202.25 09/30/25 - - Book Value 03/31/26 - 2.64 12/31/25 - 2.88 09/30/25 - 1.62 Inventory Turnover 03/31/26 - - 12/31/25 - 0.55 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©